About / Media Center
Trinity Press Releases
Filter by Type:
Trinity, a Leading Global Life Sciences Consulting Firm, Announced that it will be Presenting Two Posters at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting on March 25-28 in San Diego
Trinity, a leading global life sciences consulting firm, announced that it will be presenting two posters at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting on March 25-28 in San Diego. This event brings together national leaders to discuss the...
TGaS® Advisors Announces New Hires in Key Areas
TGaS Advisors, a division of Trinity, has announced four new additions to the benchmarking and advisory services firm.
Trinity Announces Findings from FDA-Approved Drug Performance Index
Therapies for breast cancer, multiple myeloma, and HIV ranked the highest across audit of commercial performance, therapeutic value, and R&D complexity. WALTHAM, Mass. – December 17, 2018 — Trinity, a leading global life science consulting firm, today announced the findings of...
Trinity Named a Consulting Magazine “Fastest Growing Firm” for Third Year in a Row and “Best Small Firm to Work For”
Leading global life sciences consulting firm Trinity has been named to Consulting Magazine’s 2018 lists of “Best Small Firms to Work For” as well as the magazine’s list of “Fastest Growing Firms” for the third consecutive year. Consulting Magazine’s annual ranking...
Trinity Shares Forecast Modeling Expertise in New Article for In Vivo
Experts from Trinity have published a bylined article in In Vivo. The article, titled, “You May Be Making These Drug Forecasting Mistakes,” breaks down the most common missteps in forecasting and highlights how to design and use the best models for the most accurate...
Trinity and Pfizer Present Panel Discussion on Tissue-Agnostic Cancer Drug Development
Waltham, MA—Global life sciences consulting firm Trinity today announced it will present the panel discussion, “Tissue-Agnostic Cancer Drug Development: An Emerging Paradigm Shift?” along with Pfizer and the Healthcare Businesswomen’s Association (HBA). The event, featuring perspectives from clinical, commercial, regulatory and market...
How Do You Put a Price Tag on Emerging Therapies?
Trinity issued a paper on asset valuation that explores the common methodologies for the valuation of pharma and biotech assets and highlights key considerations for capturing asset-specific nuances and accurately reflecting value.
Trinity to Acquire TGaS® Advisors
Click here to visit TGaS.com Next milestone in Trinity’s build, buy and partner growth strategy further accelerates the firm’s mission and vision to lead transformation in the life sciences industry Waltham, MA—Global life sciences consulting firm Trinity today announced it has...
Trinity Welcomes Christian Frois, PhD to Leadership Team, Among 7 Leadership Team Promotions
Boston, August 20, 2018 – Leading global life sciences consulting firm Trinity today announced that it has welcomed new Principal, Christian Frois, PhD, to the firm as well as seven other individuals to its leadership team. Trinity also welcomes new full-time hires,...
Trinity Team Attends Battle Summit to Hear How Cycle for Surviving Funding is Helping Rare Cancer Patients
Trinity’s Breanna Liponis and Alyssa Blaize recently attended Battle Summit to hear firsthand from Memorial Sloan Kettering doctors and researchers how Cycle for Survival funding is helping rare cancer patients everywhere. The team heard about important studies, initiatives and clinical trials...
Trinity Named a Forbes Best Management Consulting Firm for Third Consecutive Year
Leading global life sciences consulting firm Trinity today announced that it has been named to the Forbes America’s Best Management Consulting Firms 2018 list. Trinity has been named among the best management consulting firms every year since the inaugural ranking in...
Trinity Releases New Report on Oncology Basket Trials
Leading global life sciences consulting firm Trinity today released a new whitepaper analyzing the oncology clinical trial pipeline to determine the extent to which basket trials are being utilized and, in particular, how many are likely to be registrational studies resulting...